PRS37 - Cost Effectiveness of Nintedanib Versus Pirfenidone Treatment In Idiopathic Pulmonary Fibrosis In Turkey

Autor: Demir, O, Tetik, E, Kamaci, E, Cheynel, J
Zdroj: In Value in Health October-November 2017 20(9):A646-A646
Databáze: ScienceDirect